Publications
Sort:
Clinical Research Issue
Correlation of serum miRNAs with cognitive function and prognosis in patients with vascular dementia
Chinese Journal of Multiple Organ Diseases in the Elderly 2026, 25(4): 275-280
Published: 28 April 2026
Abstract PDF (504.6 KB) Collect
Downloads:0
Objective

To investigate the correlation of serum miR-132-3p, miR-501-3p, and miR-29c-3p with cognitive function and prognosis in patients with vascular dementia (VaD).

Methods

A study was conducted on 66 VaD patients (study group) treated at Beijing Friendship Hospital, Capital Medical University from January 2022 to December 2023 and 65 healthy individuals (control group) who underwent physical examinations in the same hospital during the same period. Spearman correlation analysis was used to analyze the relationship between serum miR-132-3p, miR-501-3p, miR-29c-3p and the mini-mental state examination (MMSE) score. Logistic regression analysis was used to analyze factors affecting the prognosis of VaD patients. Receiver operating characteristic (ROC) curves were used to determine the prognostic value of serum miR-132-3p, miR-501-3p, miR-29c-3p in VaD patients. SPSS 25.0 was used for statistical analysis. Comparison between groups was performed using t test, one-way ANOVA, or χ2 test, depending on data type.

Results

miR-132-3p, miR-29c-3p, and MMSE scores in the study group were significantly lower than those in the control group, while miR-501-3p was significantly higher (P<0.05). Serum miR-132-3p and miR-29c-3p levels were significantly lower in the moderate and severe dementia groups than those in the mild dementia group, while serum miR-501-3p levels were significantly higher than that in the mild dementia group, and the differences were statistically significant between the moderate and severe dementia groups (P<0.05). In the study group, miR-132-3p and miR-29c-3p were positively correlated with MMSE score, and miR-501-3p was negatively correlated with MMSE score (P<0.05). VaD patients with good prognosis had significantly higher levels of serum miR-132-3p and miR-29c-3p and significantly lower miR-501-3p level than those with poor prognosis (P<0.05). There were statistically significant differences (P<0.05) in the incidence of hypertension, coronary heart disease, and MMSE scores among VaD patients with different prognoses (P<0.05). Complication with hypertension and coronary heart disease, and miR-501-3p were risk factors and MMSE score, miR-132-3p, and miR-29c-3p were protective factors for the prognosis of VaD patients (P<0.05). The sensitivity in predicting the prognosis of VaD patients was 80.00% for miR-132-3p, 76.00% for miR-501-3p, 68.00% for miR-29c-3p, and 96.00% for their combination, the specificity was 87.80%, 82.93%, 82.93%, and 80.49%, respectively, and the AUC was 0.855, 0.837, 0.839, and 0.952, respectively. The Z-values for the combination versus miR-132-3p, miR-501-3p, and miR-29c-3p were 2.175 (P=0.030), 2.117 (P=0.034), and 2.249 (P=0.025), respectively. The AUC and sensitivity of the combination in predicting the prognosis of VaD patients were higher than those of individual prediction.

Conclusion

Serum levels of miR-132-3p, miR-501-3p, and miR-29c-3p are associated with cognitive function in VaD patients, and the combination of the three has a better predictive effect on the prognosis of VaD patients than individual prediction.

Total 1